Integrated, scalable solutions
 

Powering the Future of Cell and Gene Therapy Commercialization

For biopharma manufacturers already familiar with the trusted support and deep specialty pharmacy expertise of Biologics by McKesson, InspiroGeneTM by McKesson offers a next-level, purpose-built platform tailored specifically to the unique demands of cell and gene therapy (CGT) commercialization.

Backed by a variety of McKesson business units, InspiroGeneTM delivers integrated, scalable solutions—specialty pharmacy services, distribution, order-to-cash, cold chain storage and logistics, advanced patient hub services, and real-time technology platforms—to accelerate access, streamline operations and support patients through complex CGT journeys.

Key benefits for Biopharma Manufacturers:

  • Comprehensive CGT Support: InspiroGeneTM provides end-to-end solutions encompassing distribution, logistics and patient access services, streamlining the commercialization process for CGT manufacturers.
  • Scalable and Flexible Services: Suite of solutions is designed to be scalable and flexible, allowing biopharma manufacturers to tailor solutions to their specific needs, ensuring efficient and effective delivery of CGTs.
  • Proven Expertise: Backed by over a decade of McKesson’s real-world CGT expertise, InspiroGene offers tested and trusted solutions, providing confidence to manufacturers in navigating the complexities of CGT commercialization.
  • Advanced Technology Integration: InspiroLink is a purpose-built technology platform designed to optimize the experience for manufacturers, patients, payers, providers and other stakeholders, enhancing visibility and efficiency across the CGT value chain.
  • Dedicated Patient Support: InspiroCare customizable patient hub solution powered by Biologics, is designed to address the specific complexities of CGTs, offering tailored access and support services for patients, including individual case management for providers, patients and caregivers.

With InspiroGeneTM and Biologics by McKesson, biopharma manufacturers can leverage these comprehensive services to navigate the complex CGT commercialization landscape, ensuring patients have access to the life-changing treatments they need.

Financial & Access Resources

Foundational materials to support your overall collaboration with Biologics.